Edges in Network
Network | GSE25065_egf1520 - GSE25065 - SiGN-BN HC+Bootstrap |
Network Description | Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
Node | IER3 |
Upstream (Parents) |
---|
(<<) ADCY7 → IER3 |
(<<) ANKRD27 → IER3 |
(<<) BBS1 → IER3 |
(<<) CDKN1A → IER3 |
(<<) CHST2 → IER3 |
(<<) CREB3 → IER3 |
(<<) DDR1 → IER3 |
(<<) DUSP5 → IER3 |
(<<) GDF15 → IER3 |
(<<) GPX4 → IER3 |
(<<) HIF1A → IER3 |
(<<) MLPH → IER3 |
(<<) MSN → IER3 |
(<<) PLAT → IER3 |
(<<) RHOB → IER3 |
(<<) RNF138 → IER3 |
(<<) SLC16A6 → IER3 |
(<<) STC2 → IER3 |
(<<) TFF1 → IER3 |
(<<) TSG101 → IER3 |
(<<) UBE2E3 → IER3 |
(<<) WWTR1 → IER3 |
Downstream (Children) |
---|
IER3 → ADORA2B (>>) |
IER3 → CAPRIN2 (>>) |
IER3 → CBS (>>) |
IER3 → CPD (>>) |
IER3 → DLX2 (>>) |
IER3 → FOS (>>) |
IER3 → HCN4 (>>) |
IER3 → HSD17B2 (>>) |
IER3 → MAP3K14 (>>) |
IER3 → MAP6D1 (>>) |
IER3 → MAPK13 (>>) |
IER3 → MRAS (>>) |
IER3 → NMU (>>) |
IER3 → RAC1 (>>) |
IER3 → RARA (>>) |
IER3 → SOCS3 (>>) |
IER3 → SULT1A1 (>>) |
IER3 → SULT1A2 (>>) |
IER3 → TIMP1 (>>) |